Exploring AI and DCTs: A New Era of Clinical Research
In the rapidly evolving field of clinical trials, Artificial Intelligence (AI) and digital technologies play increasingly crucial roles in...
Medable’s Digital Health Solution Recognized with Prestigious Award
Medable, a leading provider of clinical trial technology, has once again secured the “Best Digital Health Solution” award at...
Farxiga Approved: Pediatric Type 2 Diabetes Treatment Breakthrough
The Food and Drug Administration (FDA) has approved FARXIGA (dapagliflozin) for pediatric patients with type-2 diabetes (T2D) aged ten...
Vector Labs and Absolute Biotech Merge
The union of Vector Laboratories and Absolute Biotech, facilitated by Thompson Street Capital Partners, is a strategic move that...
Viridian Therapeutics Launches Two Phase 3 Trials: TED
Viridian Therapeutics plans to initiate two phase 3 clinical trials (REVEAL-1 and REVEAL-2) for VRDN-003, an anti-IGF-1R antibody, in...
Why Did FDA Panel Reject Psychoactive MDMA-Assisted Therapy?
The FDA Panel has raised multiple critical concerns regarding Lykos Therapeutics’ MDMA-assisted therapy trials for treating PTSD, offering valuable...
Evrysdi’s Remarkable Results: Treating Spinal Muscular Atrophy
A recent study presented at the Cure SMA Research & Clinical Care Meeting has revealed the sustained efficacy and...
First Patient Enrolled in Monotherapy Study Evaluating Camonsertib in Non-Small Cell Lung Cancer
Repare Therapeutics, a precision oncology company, has initiated patient dosing in the expanded phase of its TRESR clinical trial,...
FDA Approves GSK’s AREXVY RSV Vaccine for At-Risk Seniors over 50
The US Food and Drug Administration (FDA) has given its approval to AREXVY (Respiratory Syncytial Virus Vaccine, Adjuvanted) for...
Unveiling Calidi’s Breakthrough Virotherapy: Revolutionizing Cancer Treatment
Calidi Biotherapeutics, a biotechnology company focused on developing anti-tumor virotherapies, has forged a partnership with SIGA Technologies to advance...